Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
HIV infection may affect the immune response to vaccination. Here the authors show that humoral response in persons living with HIV after the third dose of a SARS-CoV-2 vaccine is strong and higher than that achieved with the second dose, while cell-mediated immunity remains stable.
| الحاوية / القاعدة: | Nature Communications |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Nature Portfolio
2022-08-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s41467-022-32263-7 |
